Basis: Four-quarter free cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The free cash flow yield is N/A as of 2026-10-06T13:26:15.258Z.
Calculation as of: 2026-10-06T13:26:15.258Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 6caa0376099c5ebdf209f9b018955c4d65987c3db8176dc1b5ff0a1c5aca19bf
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FREE CASH FLOW YIELD
N/A
Bright Minds Biosciences Inc.
Market Cap
$487.30M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$483.26M
Free Cash Flow Yield
N/A
TTM Avg
18.77%
3Y Avg
18.69%
5Y Avg
14.04%
Market Cap
$491.55M
Free Cash Flow Yield
N/A
TTM Avg
3.29%
3Y Avg
4.78%
5Y Avg
5.98%
Market Cap
$478.54M
Free Cash Flow Yield
N/A
TTM Avg
3.93%
3Y Avg
3.93%
5Y Avg
3.93%
Market Cap
$471.57M
Free Cash Flow Yield
N/A
TTM Avg
1.11%
3Y Avg
1.42%
5Y Avg
1.42%
Market Cap
$517.73M
Free Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | FREE CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bright Minds Biosciences Inc. (DRUG) | $487.30M | N/A | N/A | N/A | N/A |
| Arvinas, Inc. (ARVN)vs › | $483.26M | N/A | 18.77% | 18.69% | 14.04% |
| NeoGenomics, Inc. (NEO)vs › | $491.55M | N/A | 3.29% | 4.78% | 5.98% |
| Evolus, Inc. (EOLS)vs › | $491.93M | N/A | N/A | N/A | N/A |
| Contineum Therapeutics, Inc. (CTNM)vs › | $478.54M | N/A | 3.93% | 3.93% | 3.93% |
| Cerus Corporation (CERS)vs › | $471.57M | N/A | 1.11% | 1.42% | 1.42% |
| NRC Health (NRC)vs › | $468.31M | 4.62% | 3.79% | 3.99% | 3.71% |
| Kamada Ltd. (KMDA)vs › | $461.55M | 5.74% | 4.46% | 4.74% | 4.69% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | N/A | N/A | N/A | N/A |
| Crescent Biopharma, Inc. (CBIO)vs › | $548.99M | N/A | N/A | N/A | N/A |
FCF Yield
N/A
Earnings Yield
N/A
Dividend Yield
N/A
Formula: FCF Yield = (Free Cash Flow / Market Cap) × 100
How FCF Yield is used:
FCF vs earnings: Differences between FCF yield and earnings yield can reflect capital expenditures, working capital changes, and other non-cash accounting items.
FCF Yield measures free cash flow relative to market capitalization. It compares cash generation after capital expenditures with the equity value of the company.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
